Clinical Trial Update: A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis [Phase 3]

View source ↗

Summary

A phase 3 trial reports 12-week efficacy of paracetamol 1000 mg sustained-release tablets in patients with osteoarthritis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Paracetamol 1000mg sustained-release tablets (paracetamol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pain | Phase 3 | Status: COMPLETED | Results posted: 2017-04-07